Table 1 Baseline characteristics
From: Impact of exacerbations of cystic fibrosis on muscle strength
Patients with exacerbation | Stable patients | p-value | |
|---|---|---|---|
(n = 19) | (n = 10) | ||
Age (yrs) | 25 ± 6 | 29 ± 8 | 0.14 |
Gender (male/female) | 13/6 | 6/4 | 0.70 |
BMI (kg/m2) | 20.9 ± 2.9 | 20.4 ± 2.0 | 0.63 |
Chronic PA colonization (n) | 14 (74%) | 10 (100%) | 0.07 |
CF-related diabetes mellitus (n) | 11 (58%) | 2 (20%) | 0.051 |
Pancreas insufficiency (n) | 16 (84%) | 9 (90%) | 0.67 |
Genotype ΔF508/ΔF508 (n) | 12 (63%) | 5 (50%) | 0.49 |
# Exacerbations in 12 months prior to inclusion | 1 [0–2] | 0 [0–1] | 0.09 |